1999 Subgroups in FM

Subgroups in Fibromyalgia

Selected Speakers and Their Abstracts

Michael Rosner, MD, Hendersonville, NC

	Craniocervical Decompression, Cerebral Blood Flow and Neuropsychological Dysfunction in FMS and CFS
	Neurally Mediated Hypotension: Its surgical evaluation, management and early outcome as part of the Fibromyalgia — Chronic Fatigue Syndrome

Dan Heffez, MD, Chicago Institute of Neurosurgery and Neuroresearch

	Patients With Fibromyalgia Have Quantifiable Neurological Deficits
	Surgical Treatment of Myelopathy Relieves Some Symptoms of Fibromyalgia

Thomas Milhorat, MD, State University of New York

Robert M. Bennett, MD, Oregon Health Sciences University

	A Contemporary Overview of Fibromyalgia
	Hypothalamic-Pituitary-Growth Hormone Axis Dysfunction in Fibromyalgia

Leslie Crofford, MD, University of Michigan

I. Jon Russell, MD, University of Texas Health Science Center at San Antonio

	Pain Amplifying Neurochemical Mechanisms in Fibromyalgia Syndrome (FMS)
	Functional Magnetic Resonance Imaging [MRI, fMRI] with Non-Painful or Painful Stimulation of a Tender Point [TeP] in Fibromyalgia Syndrome [FMS]

Dan Clauw, MD, Georgetown University

	Expectancy Effects on Pain Measurements Identify a Subgroup of FM Patients that Report Higher Levels of Symptomatology
	Fibromyalgia: FMRI Evidence for Increased Pressure Pain Sensitivity

Roger Kula, MD, Long Island College Hospital

Dan Malone, MD, University of Wisconsin

Roland Staud, MD, University of Florida

Muhammad B. Yunus, MD, University of Illinois at Peoria